The Senate has confirmed Scott Gottlieb, MD, President Trump’s choice to head the Food and Drug Administration (FDA). The 57-42 vote on Tuesday was largely along party lines.
A physician by training, Gottlieb previously served as deputy FDA commissioner in the George W. Bush administration. At times, he has been critical of the agency he will now run.
Gottlieb’s close ties (financial and advisory) to the industry he will now regulate, raised concerns for some Senate Democrats who fear patient safety precautions might be compromised. Many Senate Republicans agree with Gottlieb’s sentiment that FDA’s approval process can be slow and burdensome. They welcome Gottlieb’s commitment to improve the agency’s efficiency.